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Abstract
The X-chromosomal MECP2/Mecp2 gene encodes methyl-CpG-
binding protein 2, a transcriptional activator and repressor regu-
lating many other genes. We discovered in male FVB/N mice that
mild (~50%) transgenic overexpression of Mecp2 enhances
aggression. Surprisingly, when the same transgene was expressed
in C57BL/6N mice, transgenics showed reduced aggression and
social interaction. This suggests that Mecp2 modulates aggressive
social behavior. To test this hypothesis in humans, we performed
a phenotype-based genetic association study (PGAS) in >1000
schizophrenic individuals. We found MECP2 SNPs rs2239464 (G/A)
and rs2734647 (C/T; 30UTR) associated with aggression, with the
G and C carriers, respectively, being more aggressive. This finding
was replicated in an independent schizophrenia cohort. Allele-
specific MECP2 mRNA expression differs in peripheral blood
mononuclear cells by ~50% (rs2734647: C > T). Notably, the
brain-expressed, species-conserved miR-511 binds to MECP2
30UTR only in T carriers, thereby suppressing gene expression. To
conclude, subtle MECP2/Mecp2 expression alterations impact
aggression. While the mouse data provides evidence of an inter-
action between genetic background and mild Mecp2 overexpres-
sion, the human data convey means by which genetic variation
affects MECP2 expression and behavior.
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Introduction
The X-chromosomal MECP2/Mecp2 gene encodes for methyl-CpG-
binding protein 2, which can act both as a transcriptional activator
and repressor (Chao & Zoghbi, 2012). Indeed, hundreds of genes
have been estimated to be regulated, directly or indirectly, by this
protein (Chahrour et al, 2008; Cohen et al, 2008). Complete or par-
tial loss-of-function mutations of MECP2 lead to Rett syndrome, char-
acterized by a gender-dependent array of symptoms, ranging from
early loss of acquired speech and motor skills to severe mental retar-
dation and neonatal encephalopathy, among many others (Amir
et al, 1999; Bienvenu & Chelly, 2006). Interestingly, gene duplica-
tion can cause very similar symptoms (Ramocki et al, 2010), and
both down- and upregulation of MECP2 are associated with behav-
ioral core features of autism spectrum disorders (ASD) (Peters et al,
2013).
Diverse genetic mouse models, ranging from complete loss-of-
function to reduced or enhanced expression, have been generated to
study consequences of Mecp2 mutations (Chen et al, 2001; Guy
et al, 2001; Shahbazian et al, 2002; Collins et al, 2004; Moretti et al,
2005; Samaco et al, 2008; Bodda et al, 2013). In fact, there is a cor-
relation between Mecp2 “dosage” and phenotype severity, indicating
a narrow normal expression range, with deviance in both directions
being disadvantageous (Chao & Zoghbi, 2012). Along these lines,
we have previously shown that mild overexpression of Mecp2 of
~1.4–1.5 times the wildtype (WT) level induces increased seizure
propensity and aggression in male FVB/N mice, together with alter-
ations in neuronal branching sites and augmented spine density
(Bodda et al, 2013). Application of an epileptogenic compound,
pentylenetetrazole, to transgenic (TG) neurons in vitro leads to a
marked increase in amplitude and frequency of calcium spikes
(Bodda et al, 2013).
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While epileptic seizure susceptibility is a well-established result
of alterations in MECP2 expression (Shahbazian et al, 2002; Collins
et al, 2004; Chahrour & Zoghbi, 2007; Chao et al, 2010; Chao &
Zoghbi, 2012; Bodda et al, 2013), information on the behavioral
consequences of mild overexpression is still rather limited. Dou-
bling the Mecp2 expression level in mice resulted in impaired social
interaction (Samaco et al, 2012). Mecp2 deficiency, however, also
led to abnormal social behavior such as deficits in nest building,
altered social interaction and enhanced aggression (Shahbazian
et al, 2002; Moretti et al, 2005; Fyffe et al, 2008; Kerr et al, 2008;
Samaco et al, 2008, 2009; Chao et al, 2010; Pearson et al, 2012).
Taken together, tightly regulated Mecp2 expression is obviously
critical for normal function of genes involved in social behavior
(Moretti et al, 2005).
Importantly, the reported phenotypes arose from diverse genetic
backgrounds of mice carrying Mecp2 mutations, not considering
basic phenotypical differences among mouse strains (Wolfer & Lipp,
2000; Moy et al, 2009; Pietropaolo et al, 2011; O’Leary et al, 2013;
Samaco et al, 2013). For example, behavioral comparisons between
FVB/N and C57BL/6N strains revealed that FVB/N mice showed a
higher frequency of bouts during behavioral paradigms of aggres-
sion (Mineur & Crusio, 2002; Pugh et al, 2004). Thus, the genetic
background might well mask or modulate phenotypical changes
induced by alterations in Mecp2 expression.
In humans, data on aggression/impulsivity in Rett or MECP2
gene duplication syndrome are scarce. A family study characterizing
neuropsychiatric phenotypes of 9 males and 9 females with MECP2
duplications revealed a high prevalence of hostility (63%) in female
carriers. Moreover, an asymptomatic Rett mutation carrier with the
mutation located in the deletion hotspot of the MECP2 30 region has
been reported to experience episodes of uncontrolled aggression
(Huppke et al, 2006).
This study has been designed (1) to explore the role of gender
and genetic background (FVB/N versus C57BL/6N) for behavioral
phenotypes associated with mild Mecp2 overexpression in mice,
that is, altered aggression, spontaneous home cage behavior and
predisposition to epileptic seizures, and (2) in parallel to search in
humans for social behavioral consequences of common single-
nucleotide polymorphisms (SNPs) within MECP2 and (3) to strive
for mechanistic insight into SNP-related MECP2 expression differ-
ences in man.
Results
Mild Mecp2 overexpression in FVB/N and C57BL/6N mice of both
genders leaves most basic behaviors unaltered but modulates
spontaneous home cage activity
To estimate the expression of the TG protein Mecp2WT_EGFP
(~100 kDa) compared to endogenous Mecp2 (~70 kDa) in TG mice,
we performed Western blot analysis with total protein extracted
from hippocampus and cerebellum. As described previously
for FVB/N mice (Bodda et al, 2013), the relative expression of
Mecp2WT_EGFP in brain amounts to 40–50% of endogenous Mecp2 in
both strains, leading to a subtle overexpression of ~1.4- to 1.5-fold
compared to WT. Mecp2WT_EGFP TG mice of both genders and
strains (FVB/N and C57BL/6N) develop and reproduce normally,
and are devoid of any immediately obvious phenotype. Also, upon
comprehensive testing of several independent cohorts of both geno-
types and genders at different ages, all major domains of basic
behavior, that is, general activity, anxiety, motor functions, explor-
atory behavior, sensory and cognitive functions were unaltered
when compared to the respective WT littermate controls (Table 1a,
b), thus confirming and extending our earlier report on male FVB/N
TG mice (Bodda et al, 2013).
We wondered whether subtle behavioral differences upon mild
overexpression of Mecp2 are perhaps not captured by the usual
behavioral test battery. Therefore, spontaneous home cage behav-
ior was monitored continuously overnight using LABORASTM.
Indeed, we found significant differences between TG and WT
mice. There was an overall tendency of reduced locomotion,
including climbing, and increased immobility in TG as compared
to WT, noticeable across strains and genders, except for male
FVB/N mice that failed to show significant changes in locomotion
(Fig 1).
Male Mecp2 transgenic mice of both genetic backgrounds
exhibit altered territorial social behavior and aggression as
compared to their WT littermates
Based on the unexpected observation that mild overexpression of
Mecp2 leads to increased territorial aggressive behavior of male TG
versus WT FVB/N mice when exposed to FVB/N intruders (Bodda
et al, 2013), we started here a series of new experiments on the
resident-intruder paradigm: (1) We aimed at testing reproducibility
of this phenomenon in FVB/N mice exposed to younger intruder
males of C57BL/6N background, that is, per se less aggressive
intruders (Mineur & Crusio, 2002; Pugh et al, 2004). This experi-
ment yielded similar results (Fig 2A), that is, increased territorial
aggression in TG FVB/N. (2) We were interested to see whether
another genetic background, C57BL/6N, would modify the effect of
Mecp2 overexpression. However, using the same resident–intruder
protocol as in FVB/N males, no attack by C57BL/6N males was
observed (Table 1b). As male C57BL/6N mice are generally less
aggressive compared to male FVB/N (Mineur & Crusio, 2002; Pugh
et al, 2004), the resident–intruder protocol had to be slightly modi-
fied by extending the cut-off time to 10 min and increasing the
basal level of aggression using warming (Greenberg, 1972; Gaskill
et al, 2012). Even though the necessary increase in surrounding
temperature (<38°C) is far below the temperature used to test pain
sensitivity (hot plate test; temperature set to 55°C), we note here
that the pain threshold in TG and WT mice was identical
(Table 1b). Prior to testing, the home cage of the resident mouse
was placed under a heat-emitting red lamp for 20 min to obtain
mild prewarming. Further, during testing, the home cage of the resi-
dent was positioned on a warming pad (set to 38°C). Surprisingly
and opposite to FVB/N mice, the attack latency of TG C57BL/6N
was longer, pointing to reduced territorial aggression as compared
to WT littermates. In fact, within the 10 min observation, 30% of
WT and 55% of TG residents of the C57BL/6N background did not
attack the intruder at all (Fig 2A). In contrast to the clear alteration
of territorial aggression in TG versus WT male mice of both strains,
the sociability test (mouse preferred over empty cage) revealed
entirely normal behavior, indistinguishable between TG and WT
(Fig 2B).
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The unforeseen result of reduced aggression in male TG
C57BL/6N prompted us to investigate the pattern of their territorial
behavior during the resident–intruder test. We measured frequency
and duration of agonistic encounters of the resident mouse for the
first 3 min upon introducing the intruder. Whereas the latency to
initiate the first contact was comparable between male WT and
TG C57BL/6N mice (8.5  1.3 s versus 10.7  1.9 s; P = 0.35),
TG mice exhibited lower frequency and duration of follow/chase
behavior, as well as sniffing of facial and anogenital areas of the
intruder mice than their WT littermates (Fig 3).
Since this territorial behavioral pattern of male C57BL/6N TG
mice indicated somewhat reduced social interest, we hypothesized
that these mice might also display other signs of changed social
interest/competence. Indeed, nest building capacity/quality, social
dominance measured by the tube test, and ultrasound vocalization
in response to an anesthetized female intruder, revealed inferiority
or at least a strong tendency thereof in TG animals (Fig 3).
Together, these data indicate that also in Mecp2 overexpressing mice
of C57BL/6N background, territorial aggressive behavior is a central
target phenotype. In these intrinsically non-aggressive mice, how-
ever, the direction of change is exactly opposite to the FVB/N strain
and accompanied by reduced social interest and competence.
Seizure propensity is increased upon mild Mecp2 overexpression,
independent of genetic background and gender
A common characteristic neurological phenotype found in different
mouse models of mutant Mecp2, ranging from complete loss-of-
function to overexpression, is epileptic seizures (Guy et al, 2001;
Shahbazian et al, 2002; Collins et al, 2004; Chahrour & Zoghbi,
2007). We previously reported in male FVB/N TG mice a higher sus-
ceptibility to seizure induction by the GABAA receptor antagonist,
pentylenetetrazole (PTZ) (Bodda et al, 2013). This work could now
be expanded to female FVB/N TG as well as to male and female
C57BL/6N TG mice. Indeed, PTZ-induced seizure propensity is
increased across genetic backgrounds and genders (Fig 4), pointing







































































































Figure 1. Spontaneous home cage activity of FVB/N and C57BL/6N mice of both genders is modulated by mild Mecp2 overexpression. Results for male and
female mice of both strains are presented. With the exception of male FVB/N mice, locomotion, immobility and climbing reveal similar TG effects across genders and genetic
backgrounds. N = 10–28; mean  s.e.m. given.
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The startle response to acoustic stimulation is augmented upon
mild Mecp2 overexpression in female mice of both genetic
backgrounds
Deletion of Mecp2 in GABAergic neurons resulted in reduction in
the startle response to acoustic stimuli of 120db (Chao et al, 2010),
but nothing has been known regarding a potential influence of mild
Mecp2 overexpression on startling. Since Mecp2 TG mice of both
genetic backgrounds exerted an exaggerated seizure reaction to a
GABAA receptor antagonist, PTZ, we wondered whether mild over-
expression of Mecp2 might also alter the startle reflex and/or the
prepulse inhibition of the startle response (PPI). Indeed, we found
enhanced startling in female but not male Mecp2 TG mice of both
FVB/N and C57BL/6N background (Fig 4). No changes in the
percentage of PPI were observed in any strain or gender (Table 1a,b).
Similar findings that the startle response at 120db does not necessar-
ily affect overall PPI were reported in the context of a study on
mouse inbred strain differences (Paylor & Crawley, 1997).
MECP2 SNP distribution is comparable in healthy and
schizophrenic individuals
Since our mouse studies revealed aggressive social behavior as a
central phenotype modulated by subtle Mecp2 overexpression, we
started a hypothesis-driven analysis on subjects of the GRAS
(G€ottingen Research Association for Schizophrenia) data collection
(Ribbe et al, 2010). Genotyping for association analyses was
performed for 4 SNPs located in the X-chromosomal MECP2 gene
with reasonably high minor allele frequency (Fig 5A). At first, a
potential genetic risk condition of the selected SNPs for schizophre-
nia was assessed: A case–control study comparing allele frequencies
of the 4 genotyped SNPs rs2239464, rs3027933, rs2075596, and
rs2734647 in 1052 GRAS patients versus 1248 healthy controls was
performed separately for men and women. All markers fulfilled
Hardy–Weinberg criteria, and no significant associations with
diagnosis were detected (Fig 5B,C). Due to strong linkage disequilib-
rium (LD) between markers, only rs2239464 and rs2734647 were
considered for the phenotype-based genetic association study
(PGAS, inclusion criterion r² < 0.8) (Fig 5D).
Normal genetic variation of MECP2 influences aggression and
impulsivity in man
We next selected aggression-related variables from the GRAS pheno-
typical data collection and tested their association with the 2
selected MECP2 SNPs separately in men and women. Poor impulse
control and a further trait reflecting behavioral expression of impul-
sive aggression (excitement) were chosen. For both, SNP rs2734647
in the 30UTR (Table 2) and for SNP rs2239464 (Table 3), significant
associations with these traits were found in men, with C carriers
and G carriers (the major alleles), respectively, being more aggres-
sive. Sociodemographic and clinical measures potentially confound-
ing these results did not differ between genotype groups. The
nominally significant result for years of education in males (SNP
rs2734647) was accounted for by including it as a covariate in all
models with target measures as dependent variables. In contrast, for
women, no statistically significant results were obtained. The
phenotype–genotype relationships could be reproduced in a small
independent sample of schizophrenic men (Table 4). Taken
together, an association of MECP2 genotypes with readouts of
aggression was found in two independent cohorts of men.
SNP rs2734647 in the 30UTR affects miR-511 binding and
gene expression
To examine possible functional implications of SNP rs2734647 in
the 30UTR on microRNA (miR)-dependent regulation of gene expres-
sion, in silico analyses were performed using TargetScan (Release
6.2) (Lewis et al, 2005; Grimson et al, 2007) and PITA (Kertesz

































































Figure 2. Territorial aggressive behavior in male mice is influenced by Mecp2 overexpression and genetic background.
A Latency to attack in the resident-intruder test is significantly reduced in male FVB/N TG mice but increased in C57BL/6N. Note the different cut-off for the 2 strains.
B Sociability testing in the tripartite chamber reveals a highly significant preference of male mice, independent of the genetic background, for a stranger mouse as
compared to an object (empty cage). Data information: N = 10–24; mean  s.e.m. given.
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sites comprising the SNP rs2734647 position (i.e., c.*3638A>G).
Allele-specific differences of the predicted DDG values, indicating
strength of miR binding, are summarized in Fig 6A. While miR-
4711-3p and miR-511 are predicted to show preferential binding
in case of the presence of the T-allele, miR-515-3p has a strong
negative DDG only in case of the C-allele, and miR-519e lacks a
strong allele preference. In vitro luciferase assays using HEK293
cells revealed significantly reduced luciferase activity in case of
co-transfection of the plasmid carrying the T-allele with both miR-
4711-3p and miR-511 (Fig 6B). Co-transfection with miR-515-3p or
miR-519e did not lead to luciferase activity reduction for either
rs2734647 T or C (Fig 6B). In luciferase assays using N2a cells, the
positive result was only replicated for miR-511 (Fig 6C). In sum-
mary, these data strongly suggest miR-511 as rs2734647 genotype-
dependent candidate for MECP2 regulation in humans. For the sake
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Figure 3. Male TG C57BL/6N mice show reduced territorial social interaction as well as inferior social competence. Upper 2 rows: Frequency and duration of
determinants of territorial social interaction, that is, follow/chase behavior, nose/snout sniff and anogenital sniff, are consistently reduced in TG carriers. Lower row: TG mice
are inferior in nest building, social dominance behavior and ultrasound vocalization. N = 10–23; mean  s.e.m. given.
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in the cell lines used for transfection. Whereas mmu-miR-511 levels
were under the detection limit in N2a cells, hsa-miR-511 was clearly
expressed in HEK293 cells (3.59 × 103). However, since we always
used negative, that is, non-miR-transfected controls, Luciferase
assay results are unlikely to have been affected.
miR-511 is expressed in aggression-relevant human
brain regions
Since miR-511 seems to be an important modulator of rs2734647
genotype-dependent MECP2 expression in humans, we asked
whether this miR would be detectable in brain regions relevant for
impulsivity and aggression (frontal and prefrontal cortex, temporal
cortex, occipital cortex, hippocampus, and amygdala). Placenta was
used as developmental control tissue. In all regions examined, miR-
511 expression was found (Fig 6D). Importantly, the same holds
true for MECP2 using primers amplifying either MECP2_e2 only or
both isoforms (Fig 6E). In contrast, miR-4711-3p expression was not
detected (data not shown), at least questioning a role of this miR for
MECP2 regulation in the adult human brain. In the adult C57BL/6N
versus FVB/N mouse brain, the expression of miR-511 was low and
comparable between strains in cortex (2.39 × 105 versus
3.71 × 105), hippocampus (6.45 × 105 versus 3.78 × 105), and
cerebellum (2.22 × 105 versus 2.36 × 105). Strong expression
was found in embryonic tissue (C57BL/6N embryo head E17:
1.83 × 103; embryo body: 2.26 × 103), and highest in cultured
microglia (13.02 × 103).
Peripheral blood mononuclear cells (PBMC) of male rs2734647
T-carriers show lower MECP2 expression
Since miR-511 was shown to be expressed in dendritic cells and
macrophages (Tserel et al, 2011), we investigated the hypothesized
allele-specific downregulation of MECP2 expression in PBMC of
male subjects. Indeed, a significantly lower expression in T carriers
versus C carriers (amounting to around 50%) was detected with
primers amplifying both MECP2 isoforms, whereas MECP2_e2 alone
showed no expression difference dependent on the rs2734647 geno-
type (Fig 6F). This result may indicate that in T carriers mainly the
MECP2_e1 isoform is affected, at least in PBMC, potentially related
to isoform-specific different lengths of the MECP2 30UTR (Coy et al,
1999).
Sequence variation of miR-511 in mouse and man underlines the
importance of an interaction with the MECP2 30UTR
A perfect seed match of human hsa-miR-511 with the MECP2 30UTR



















































































Figure 4. Pentylenetetrazole-induced seizure propensity is increased upon mild Mecp2 overexpression independent of strain and gender, whereas the
startle response is augmented in females only. Upper row: Higher seizure scores are found in TG carriers across gender and genetic backgrounds. N = 6–14; Lower row:
Significant increase in the startle response is observed only in female mice of both genetic backgrounds. N = 11–28; mean  s.e.m. given.
10
EMBO Molecular Medicine MECP2 expression differences in aggression Martesa Tantra et al
EMBO Molecular Medicine ª 2014 The Authors
in luciferase activity in contrast to the C-allele, which results in a
mismatch in the seed binding region. C is the conserved ancestral
allele found in multiple other mammalian species, including mouse.
Strikingly, the seed sequence of mouse mmu-miR-511 differs from
hsa-miR-511 exactly regarding the nucleotide complementary to the
SNP position (Fig 6G). Thus, mmu-miR-511 shows an ideal seed
match to the mouse 30UTR, whereas hsa-miR-511 perfectly fits to
the human 30UTR carrying the T-allele. This observation may
emphasize the importance of the miR-511 interaction with MECP2.
Notably, screening of available data from Jackson Laboratories
(http://www.jaxlab.org) revealed that the two mouse lines
employed here are not polymorphic for the Mecp2 30UTR allele or
the miR-511 sequence. It would, however, be interesting to investi-
gate whether non-inbred mice are polymorphic for the respective
alleles.
Discussion
The present study shows that mildly increased Mecp2/MECP2
expression leads to alterations in male social aggression. Using
C57BL/6N versus FVB/N mice (with their known inherent strain dif-
ferences in aggressive behavior) (Mineur & Crusio, 2002; Pugh et al,
2004) as models, we demonstrate that the direction of change upon
mild Mecp2 overexpression in this behavioral target domain is sub-
ject to modification by the genetic background. In other words, the
resulting lower or higher social aggression depends on the basic
genetic make-up of a particular subject. Hints of MECP2 influencing
aggressive behavior could also be shown in two independent
cohorts of schizophrenic men, with a polymorphism in the 30UTR of
the gene co-determining both the level of MECP2 expression as well




N (%) P (OR, [95% CI])
GRAS patients GRAS controls allelic, d.f.=1
Females
rs2239464
GG 205 (61.4) 307 (64.0)
0.45 (1.10, [0.86 - 1.40])GA 117 (35.0) 158 (32.9)
AA 12   (3.6) 15   (3.1)
rs3027933
CC 236 (70.7) 341 (71.0)
0.80 (1.04, [0.79 - 1.36])CG 90 (26.9) 130 (27.1)
GG 8   (2.4) 9   (1.9)
rs2075596
GG 239 (71.3) 344 (71.7)
0.75 (1.05, [0.79 - 1.37])GA 87 (26.0) 127 (26.5)
AA 9   (2.7) 9   (1.9)
rs2734647
CC 234 (69.9) 337 (70.2)
0.77 (1.04, [0.80 - 1.36])CT 91 (27.2) 132 (27.5)
TT 10   (3.0) 11   (2.3)
Males
rs2239464
G 582 (81.4) 617 (80.3)
0.60 (0.93, [0.72 - 1.21])
A 133 (18.6) 151 (19.7)
rs3027933
C 606 (84.8) 655 (85.3)
0.77 (1.04, [0.78 - 1.39])
G 109 (15.2) 113 (14.7)
rs2075596
G 613 (85.2) 660 (85.9)
0.81 (1.04, [0.78 - 1.39])
A 104 (14.5) 108 (14.1)
rs2734647
C 608 (84.8) 646 (84.1)
0.71 (0.95, [0.72 - 1.26])











SNP rs# Test for HWE deviation (females)
P (total) P (controls) P (cases)
rs2239464 0.19 0.39 0.41
rs3027933 0.51 0.49 1.00
rs2075596 0.89 0.59 0.68




3`UTR can vary in length
2 3 4
Figure 5. Basic genetics of MECP2: Gene structure, Hardy-Weinberg statistics, linkage disequilibrium, and case-control analysis in schizophrenic (GRAS)
patients and healthy individuals.
A Schematic overview of MECP2 isoforms e1 and e2, including SNP positions. Digits depict exon numbers, solid black lines exon usage for the respective isoform.
Dashed lines denote SNP positions. Black fillings in boxes denote coding sequence, isoform-specific in exons 1 and 2.
B Test for deviation from Hardy-Weinberg-Equilibrium (HWE) in females only due to X-chromosomal location of MECP2.
C Case–control association analysis - separate for both genders - reveals similar distribution of SNPs in patients and controls.
D Linkage disequilibrium for all included GRAS patients and controls.
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men found in PBMC (around 50%) is in the range of the transgenic
overexpression in both mouse strains, emphasizing the physiologi-
cal significance of these findings as well as of our mouse models for
studying behavioral consequences of a normal “Mecp2 dose range”.
Even though in both schizophrenia samples, higher expression of
MECP2 (30UTR SNP rs2734647 C carriers lack suppressibility by
miR-511) was associated with higher aggression, it has to be consid-
ered that also humans are not an isogenic population. One might
Table 2. Phenotype comparison of GRAS patients by MECP2 SNP rs2734647 genotypes
Males (GRAS sample)a C T P-value (F/Z/v2 value)b
Target variablesc N = 491 to 608 N = 73 to 109
Poor impulse control, mean  s.d. [range] 1.72  1.12 [1 to 6] 1.39  0.76 [1 to 4] 0.0001 (F = 14.65)
Excitement, mean  s.d. [range] 2.05  1.30 [1 to 7] 1.82  1.13 [1 to 6] 0.034 (F = 4.52)
Control variables
Sociodemographic variables
Age (at examination), years, mean  s.d. [range] 37.40  12.09 [17 to 78] 37.02  11.99 [21 to 71] 0.736 (Z = 0.34)
Education, years, mean  s.d. [range]d 12.11  3.10 [0 to 24] 11.32  2.48 [8 to 18] 0.020 (Z = 2.33)
Unemployment, No. (%) 107 (17.8) 22 (21.0) 0.446 (v2 = 0.58)
Clinical variables
PANSS general score, mean  s.d. [range]e 30.57  10.82 [15 to 81] 31.88  9.73 [16 to 55] 0.542 (Z = 0.61)
PANSS negative score, mean  s.d. [range] 18.04  7.67 [7 to 46] 19.23  7.31 [7 to 40] 0.070 (Z = 1.81)
PANSS positive score, mean  s.d. [range]f 11.61  5.25 [6 to 34] 11.39  5.15 [6 to 30] 0.667 (Z = 0.43)
Cognition composite score, mean  s.d. [range]g 0.09  0.84 [2.4 to 2.2] 0.00  0.84 [2.1 to 1.7] 0.543 (F = 0.37)
Chlorpromazine equivalents, mean  s.d. [range] 688  644 [0 to 4511] 725  734 [0 to 6324] 0.394 (Z = 0.85)
GAF score, mean  s.d. [range] 45.48  16.35 [5 to 90] 46.94  15.45 [15 to 85] 0.375 (Z = 0.89)
Females (GRAS sample)a CC CT TT
P-value
(F/Z/v2 value)b
Target variablesc N = 194 to 234 N = 73 to 91 N = 8 to 10
Poor impulse control, mean  s.d. [range] 1.73  1.15 [1 to 7] 1.57  0.94 [1 to 5] 1.60  1.07 [1 to 4] 0.729 (F = 0.31)
Excitement, mean  s.d. [range] 2.11  1.30 [1 to 7] 1.93  1.31 [1 to 7] 1.50  0.53 [1 to 2] 0.277 (F = 1.29)
Control variables
Sociodemographic variables
Age (at examination), years, mean  s.d.
[range]
43.41  12.90 [18 to 76] 41.82  12.47 [19 to 72] 43.52  12.10 [20 to 58] 0.657 (v2 = 0.84)
Education, years, mean  s.d. [range]d 12.61  3.36 [8 to 27] 12.14  2.83 [8 to 21] 12.15  3.76 [8 to 19] 0.750 (v2 = 0.58)
Unemployment, No. (%) 25 (10.9) 12 (13.6) 4 (40.0) 0.176 (v2 = 1.83)
Clinical variables
PANSS general score, mean  s.d. [range]e 33.04  12.10 [15 to 69] 32.38  12.25 [15 to 72] 31.30  10.64 [19 to 54] 0.872 (v2 = 0.28)
PANSS negative score, mean  s.d. [range] 18.13  8.50 [7 to 44] 17.82  8.11 [7 to 36] 19.30  9.36 [7 to 39] 0.904 (v2 = 0.20)
PANSS positive score, mean  s.d. [range]f 12.25  6.03 [6 to 32] 11.41  5.25 [6 to 30] 11.40  4.40 [6 to 18] 0.650 (v2 = 0.86)
Cognition composite score, mean  s.d.
[range]g
0.02  0.83 [2.0 to 1.9] 0.19  0.90 [2.0 to 2.0] 0.08  0.83 [1.5 to 1.1] 0.090 (F = 2.43)
Chlorpromazine equivalents, Mean  s.d.
[range]
677  839 [0 to 7375] 608  685 [0 to 4375] 640  512 [150 to 1680] 0.614 (v2 = 0.98)
GAF score, mean  s.d. [range] 45.44  19.07 [12 to 90] 47.07  18.60 [8 to 90] 48.80  14.73 [25 to 70] 0.472 (v2 = 1.50)
All P ≤ 0.05 are set in boldface.
GAF, global assessment of functioning
aDue to missing data, sample sizes vary.
bFor statistical methods, Mann–Whitney U/Kruskal–Wallis test (women) or Chi-square tests and for models including covariates ANCOVAs (target variables and
cognition composite score) were used.
cANCOVA with education, age at examination, negative symptoms (PANSS) and medication status (chlorpromazine equivalent) as covariates.
dYears spent in education system; patients currently in school or educational training included (score 0).
eItem 14 (target variable) excluded from sum score.
fItem 4 (target variable) excluded from sum score.
gANCOVA with age, negative symptoms (PANSS) and medication status (chlorpromazine equivalent) as covariates.
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thus, in analogy to our observation in different mouse strains, pre-
dict a human population with reduced aggression as suggested by
the C57BL/6N data (i.e., a bimodal aggression distribution when
combining different genetic backgrounds).
Although the results for women show a similar tendency for poor
impulse control and excitement as aggression readouts, they are far
from reaching significance, likely due to the smaller number of
individuals, but certainly also to the fact that MECP2 is X chromo-
somal. Homozygous T carriers in the female sample are therefore
expectedly very rare.
In our translational PGAS approach, we had the chance to explore
the aggression association of MECP2 genotypes in a phenotypically
very well-characterized large sample of schizophrenic individuals
(Ribbe et al, 2010), and we replicated the association findings in a
Table 3. Phenotype comparison of GRAS patients by MECP2 SNP rs2239464 genotypes
Males (GRAS sample)a G A P-value (F/Z/v2 value)b
Target variablesc N = 469 to 582 N = 94 to 134
Poor impulse control, mean  s.d. [range] 1.72  1.12 [1 to 6] 1.44  0.81 [1 to 4] 0.001 (F = 10.84)
Excitement, mean  s.d. [range] 2.05  1.31 [1 to 7] 1.83  1.11 [1 to 6] 0.056 (F = 3.67)
Control variables
Sociodemographic variables
Age (at examination), years, mean  s.d. [range] 37.31  12.07 [17 to 78] 37.27  12.12 [21 to 71] 0.918 (Z = 0.10)
Education, years, mean  s.d. [range]d 12.10  3.10 [0 to 24] 11.50  2.52 [8 to 20] 0.063 (Z = 1.86)
Unemployment, No. (%) 101 (17.6) 28 (21.5) 0.294 (v2 = 1.10)
Clinical variables
PANSS general score, mean  s.d. [range]e 31.71  10.84 [15 to 81] 31.36  9.83 [16 to 55] 0.966 (Z = 0.04)
PANSS negative score, mean  s.d. [range] 18.13  7.66 [7 to 46] 18.61  7.48 [7 to 40] 0.420 (Z = 0.81)
PANSS positive score, mean  s.d. [range]f 11.67  5.29 [6 to 34] 11.20  4.99 [6 to 30] 0.358 (Z = 0.92)
Cognition composite score, mean  s.d. [range]g 0.09  0.83 [2.4 to 2.2] 0.05  0.88 [2.1 to 1.9] 0.842 (F = 0.40)
Chlorpromazine equivalents, mean  s.d. [range] 691  635 [0 to 4511] 688  700 [0 to 6324] 0.936 (Z = 0.08)
GAF score, mean  s.d. [range] 45.11  16.26 [5 to 90] 45.27  15.7 [15 to 85] 0.045 (Z = 2.00)
Females (GRAS sample)a GG GA AA
P-value
(F/Z/v2 value)b
Target variablesc N = 173 to 206 N = 94 to 117 N = 10 to 13
Poor impulse control, mean  s.d. [range] 1.74  1.18 [1 to 7] 1.62  0.99 [1 to 5] 1.23  0.60 [1 to 3] 0.243 (F = 1.42)
Excitement, mean  s.d. [range] 2.12  1.29 [1 to 7] 1.98  1.31 [1 to 7] 1.62  1.12 [1 to 5] 0.416 (F = 0.88)
Control variables
Sociodemographic variables
Age (at examination), years, mean  s.d. [range] 43.65  13.11 [18 to 76] 42.01  12.15 [19 to 72] 42.66  12.37 [20 to 58] 0.665 (v2 = 0.82)
Education, years, mean  s.d. [range]d 12.66  3.32 [8 to 27] 12.22  3.05 [8 to 21] 11.96  3.28 [8 to 19] 0.538 (v2 = 1.24)
Unemployment, No. (%) 20 (10.0) 17 (14.5) 4 (30.8) 0.056 (v2 = 5.77)
Clinical variables
PANSS general score, mean  s.d. [range]e 32.92  12.42[15 to 69] 33.11  11.79 [15 to 72] 30.23  11.42 [19 to 54] 0.690 (v2 = 0.74)
PANSS negative score, mean  s.d. [range] 18.07  8.49 [7 to 44] 18.20  8.37 [7 to 39] 17.62  8.48 [7 to 39] 0.961 (v2 = 0.08)
PANSS positive score, mean  s.d. [range]f 12.28  5.99 [6 to 32] 11.74  5.55 [6 to 32] 10.00  4.26 [6 to 18] 0.440 (v2 = 1.64)
Cognition composite score, mean  s.d. [range]g 0.01  0.84 [2.0 to 1.9] 0.20  0.87 [2.0 to 2.0] 0.03  0.75 [1.5 to 1.4] 0.049 (F = 3.06)
Chlorpromazine equivalents, mean  s.d. [range] 671  852[0 to 7375] 638  702 [0 to 4370] 650  504 [150 to 1680] 0.811 (v2 = 0.41)
GAF score, mean  s.d. [range] 46.07  19.12 [15 to 90] 45.13  18.87 [8 to 90] 51.38  12.35 [25 to 70] 0.323 (v2 = 2.26)
All P ≤ 0.05 are set in boldface.
aDue to missing data, sample sizes vary.
bFor statistical methods, Mann–Whitney U/Kruskal–Wallis test (women) or Chi-square tests and for models including covariates ANCOVAs (target variables and
cognition composite score) were used.
cANCOVA with education, age at examination, negative symptoms (PANSS) and medication status (chlorpromazine equivalent) as covariates.
dYears spent in education system; patients currently in school or educational training included (score 0).
eItem 14 (target variable) excluded from sum score.
fItem 4 (target variable) excluded from sum score.
gANCOVA with age, negative symptoms (PANSS) and medication status (chlorpromazine equivalent) as covariates.
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second, independent cohort of schizophrenic men. Therefore, we
cannot state with certainty at this point that the phenotype associa-
tion holds true in the same way for healthy individuals. Neverthe-
less, apart from the supporting data obtained for healthy mice, it has
to be emphasized that aggression is not a specific or unique symp-
tom in schizophrenia. Also, the range of aggressive features in the
whole GRAS patient sample follows a normal distribution, extending
from very low to very high aggression scores.
Along the same lines, the case–control study presented here,
including 1052 cases and 1248 controls, fails to attribute to MECP2
any schizophrenia risk gene role. In some contrast, a recent study
reported in a Han Chinese population an association of rs2734647 C
with the disease (498 cases versus 2025 controls, replicated in 1027
cases versus 1005 controls) (Wong et al, 2013). Although we did
not even find a respective trend (Fig 5C), we cannot entirely exclude
limited power of our case–control approach. On the other hand, the
association might well be population-specific. In any case, a poten-
tial risk gene status, even if confirmed by future GWAS including
X-chromosomal genotypes, will not be dramatic considering the large
number of individuals needed for its demonstration. Instead, MECP2
is most likely disease-independently involved in the regulation of a
basic mammalian behavioral phenotype, that is, aggression. Inter-
estingly, carriers of the minor allele of MECP2 SNP rs2239464 were
previously shown to have decreased cortical surface area in brain
regions such as the cuneus (Joyner et al, 2009), which is associated
with inhibitory control in patients with bipolar disorder (Haldane
et al, 2008).
In further support of an association between MECP2 and aggres-
sion, impulse control alterations in individuals with MECP2/Mecp2
gene duplication syndrome have been reported (Ramocki et al,
2009), even though the findings of the present study are more rele-
vant for the understanding of physiological gene-dose effects on
social behavior. Importantly, Mecp2/MECP2 functions as transcrip-
tional regulator targeting hundreds of other genes (Chen et al, 2003;
Sun & Wu, 2006; Bird, 2008; Chahrour et al, 2008; Ben-Shachar
et al, 2009; Wu et al, 2010). Thus, it is most likely a whole pattern
Table 4. Phenotype comparison of replication sample patients by MECP2 SNPs rs2734647 and rs2239464
rs2734647 genotypes
P-value (Z/v2 value)aMales (replication sample) C T
Target variablesb N = 322 N = 63
Poor impulse control, mean  s.d. [range] 3.16  1.91 [1 to 7] 2.86  1.93 [1 to 6] 0.05 (Z = 1.64)
Excitement, mean  s.d. [range] 3.79  1.60 [1 to 7] 3.52  1.56 [1 to 7] 0.09 (Z = 1.33)
Control variables
Age (at examination), years, mean  s.d. [range] 35.34  10.91 [19 to 65] 36.63  10.80 [18 to 67] 0.16 (Z = 1.01)
Education rating,% low, intermediate, high education level 47.8%, 22.4%, 29.8% 42.9%, 30.2%, 27.0% 0.21 (v2 = 1.78)
rs2239464 genotypes
P-value (Z/v2 value)aMales (replication sample) G A
Target variablesb N = 308 N = 77
Poor impulse control, mean  s.d. [range] 3.19  1.92 [1 to 7] 2.82  1.89 [1 to 6] 0.03 (Z = 1.91)
Excitement, mean  s.d. [range] 3.83  1.60 [1 to 7] 3.42  1.58 [1 to 7] 0.02 (Z = 2.07)
Control variables
Age (at examination), years, mean  s.d. [range] 35.28  11.01 [19 to 65] 36.66  10.40 [18 to 67] 0.12 (Z = 1.23)
Education rating,% low, intermediate, high education level 48.7%, 22.1%, 29.2% 40.3%, 29.9%, 29.9% 0.14 (v2 = 2.53)
All P ≤ 0.05 are set in boldface.
aFor statistical methods, Mann–Whitney U or Chi-square tests were used (all P-values one-sided).
bMann–Whitney U-tests with standardized residuals from linear regression with target variables as dependent variables and age at examination and negative
symptoms as independent variables.
Figure 6. SNP rs2734647 in the 30UTR of MECP2: Search for mechanistic insight.
A Human miRNAs predicted to bind to the MECP2 30UTR in an rs2734647 allele-specific manner. The bases corresponding to the SNP position are black-shadowed.
Numbers left and right of the nucleotide sequence refer to its base-pair position within the miRNA sequence.
B, C Luciferase assay results showing relative luciferase activity in HEK293 and N2a cells after co-transfection of candidate miRNAs with phRL-TK rs2734647C, or
rs2734647T, respectively; mean  s.e.m.; N = 7 (refers to biological replicates) for all conditions. Statistical significance was calculated relative to the non-
transfection control (100%).
D, E Relative expression of hsa-miR-511 and of MECP2 isoform 2 (MECP2 e2) or both isoforms (MECP2 e1&2) in aggression/impulsivity – relevant brain areas: FC=frontal
cortex, PFC, prefrontal cortex; TC, temporal cortex; OC, occipital cortex; HC, hippocampus; AM, amygdala; as well as in placenta (N = 1) as control tissue. Numbers
of individual brains included in the analysis are given in brackets; mean  s.e.m.
F Relative expression of MECP2 e2 or MECP2 e1&2 in peripheral blood mononuclear cells (PBMC) of male patients dependent on rs2734647 genotype; N numbers of
individuals in brackets; mean  s.e.m.
G Alignment of human and mouse MECP2 30UTRs around rs2734647 SNP position (black-shadowed) and human and mouse miR-511, illustrating a perfect species-
specific seed match; hsa-miR-511 perfectly matches the human MECP2 30UTR in case of rs2734647 T. Additional mismatches are gray-shadowed.
▸
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of genes—directly or indirectly influenced by this regulator—that
primes nuances of aggressive social behavior. As an example,
changes in the expression of a Mecp2 regulated gene, Prom1, are
associated with domestication and aggressive behavior in animals
(Albert et al, 2012; Gopisetty et al, 2012). Furthermore, Mecp2 is
known to control expression of brain-derived neurotrophic factor
(Bdnf) (Martinowich et al, 2003), which in turn is involved in the
regulation of aggression (Ito et al, 2011).
Aggression seems to be a strong target phenotype of mild Mecp2
overexpression independent of the genetic background, since these
expression changes did not lead to alterations in basic behavior,
including motor, sensory and cognitive functions. Male and female
TG mice of both the FVB/N and C57BL/6N genetic backgrounds dis-
played basic behavior comparable to their WT littermates. Apart
from aggression, only home cage activity, seizure propensity and
startle response were influenced by mild Mecp2 overexpression in a
fashion widely independent of the genetic background.
There have been reports on sexual dimorphism with respect to
Mecp2 expression and function in the brain. For instance, in amy-
gdalae and ventromedial hypothalamus, male rats express less
Mecp2 as compared to females (Kurian et al, 2007, 2008). Further-
more, conditional knockout of Mecp2 during amygdala development
caused subtle modifications of juvenile play behavior in male but
not female rats (Kurian et al, 2008). These findings may indicate a
role of Mecp2 in gender-specific modulation of behavior. In the pres-
ent work, however, sexual dimorphism was consistently observed
only with the startle response in a genotype and genetic background
independent manner.
Even though the explicit situations are still unknown in which
miR-511 regulated MECP2/Mecp2 expression might be of particular
physiological relevance, any kind of inflammation in the brain for
instance could play a pivotal role, considering the relatively high
expression found here in mouse microglia. The distinct suppression
of MECP2 expression by miR-511 in SNP rs2734647-T carriers
reported here may even be considered as a future treatment target
in MECP2 gene duplication syndrome. In any case, the high conser-
vation of the interaction between miR-511 and MECP2 in both
mouse and man makes a specific significance of their interplay very
likely. This significance is further supported by the here demon-
strated co-expression of MECP2 and miR-511 in human brain areas
pivotal for aggression and impulsivity regulation (Brower & Price,
2001; Horn et al, 2003; Berlin et al, 2004; Bauman et al, 2006; Zetz-
sche et al, 2007; Siever, 2008; Whelan et al, 2012). Interestingly,
miR-511 expression was found here also in different mouse brain
areas, with levels comparable across both genetic backgrounds.
To conclude, MECP2/Mecp2 has been shown here to be a regula-
tor of social aggressive behavior in mouse and man, with the genetic
background playing an important modifier role.
Materials and Methods
Mice
All mouse experiments have been approved by the Animal Care and
Use Committee of Lower Saxony, Oldenburg, Germany. The genera-
tion of Mecp2WT_EGFP TG mice with a 1.4–1.5-fold Mecp2 overexpres-
sion on FVB/N background has been described in detail previously
(Bodda et al, 2013). Briefly, a bacterial artificial chromosome (BAC)
clone, pBAC_B22804, containing 120 Kb of murine genomic frag-
ment with the intact Mecp2 gene and the flanking Opsin1 and Irak1
genes was used for generating the transgenic construct (Kifayathul-
lah et al, 2010). To generate the pBAC_Mecp2WT_EGFP construct,
the enhanced green fluorescent protein/kanamycin-resistant gene
(EGFP/kan) cassette was PCR amplified using pEGFP1 vector as
template with primers containing 50-bp flanking sequence from
either side of the Mecp2 stop codon. The endogenous stop codon
was replaced by two glycine residues inframe between the Mecp2
protein and the EGFP protein to facilitate the two proteins to fold
and function independently. The amplified EGFP/Kan cassette was
electroporated into E.coli harboring the BAC clone and pGET recom-
bination system, to facilitate the homologous recombination of
EGFP/Kan cassette at the site of stop codon of Mecp2. The correct
insertion of EGFP/Kan cassette after the recombination event into
the BAC clone was confirmed by sequencing. The Mecp2 flanking
genes, Opsin1 and Irak1 were deleted from the modified BAC clone
using additional BAC recombineering with zeocin selection cassette
(containing the BAC homology arms and zeocin antibiotic marker
gene driven by EM7 promoter from pSELECT vector) (InvivoGen,
Toulouse, France), to avoid any additional phenotype arising from
the overexpression of these genes. During the process of Opsin1
deletion, a MluI restriction site was introduced into BAC clone. The
final BAC construct pBAC_Mecp2WT_EGFP was linearized with
MluI restriction enzyme and micro-injected into the male pronuclei
of the fertilized mouse oocytes derived from the FVB/N strain. Next,
the injected oocytes were transplanted into the uteri of the foster
mothers. Genomic DNA isolated from tail biopsies was analyzed for
the presence of the transgene by PCR. Because the transgene was
not confirmed to be localized to the X chromosome, translational
relevance with respect to modeling mosaicism resulting from X
chromosome loss is limited.
To create a comparator congenic strain for behavioral analyses,
Mecp2 TG FVB/N mice were backcrossed for 10 generations to the
C57BL/6N background. For experiments reported here, male and
female Mecp2WT_EGFP TG (hemizygous) and their WT littermates on
either FVB/N or C57BL/6N backgrounds were used. Tail biopsies
were taken before weaning to obtain genomic DNA for genotyping
(Kifayathullah et al, 2010; Bodda et al, 2013). Western blot and
qPCR analyses for TG expression estimation were performed as
described previously (Bodda et al, 2013).
Behavioral analyses
After weaning and during the whole period of behavioral testing,
mice were housed individually in standard plastic cages
(26.5 × 20 × 14 cm) and kept under temperature-controlled envi-
ronment (21  2°C) on 12 h light/dark cycle with food and water
ad libitum, unless stated otherwise. Single housing was necessary
since male FVB/N mice exhibited extremely aggressive behavior in
a group-housed setting. In order to avoid housing differences as con-
founding variables, we decided to single-house all mice, indepen-
dent of gender and strain. All experiments were conducted by
investigators unaware of the genotype (“blinded”), during the light
phase of the day (between 8:00 am and 6 pm, except for automated
home cage behavioral assessment. Several independent cohorts of
mice (genders and strains tested separately, starting at 5 weeks of
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age) were run through a battery of tests covering altogether basic
behavioral, sensory, motor, cognitive and social functions (for over-
view see Table 1a,b). The order of tests was always oriented toward
increasing invasiveness and performed as published in detail earlier
(Jamain et al, 2008; El-Kordi et al, 2012; Bodda et al, 2013):
Elevated plus maze (anxiety), open field (spontaneous activity),
hole board (exploratory behavior), grip strength and rotarod (motor
force, balance and coordination), marble burying (stereotypies and
obsessive–compulsive behaviors), prepulse inhibition of the startle
response (sensorimotor gating), hearing test (startle curve upon
random presentation of stimulus intensities from 65 dB to 120 dB),
Y-maze (working memory), novel object recognition, visual cliff
(vision), sociability (social preference, i.e., other mouse over
object), buried food finding (olfaction), sucrose preference (anhedo-
nia), hot plate test (pain sensation), and hole board (working and
reference memory). Moreover, automated home cage behavior
analysis (LABORASTM), ultrasound vocalization recording, nest
building (social competence), social tube (dominance), resident–
intruder paradigm (aggression) and seizure propensity (seizure
induction by pentylenetetrazole) were performed as indicated
(Table 1a,b). In the following, the here relevant tests (with signifi-
cant results) will be described in detail, while for the other tests the
reader is politely referred to previous publications of ourselves and
others (Kuc et al, 2006; Jamain et al, 2008; Mandillo et al, 2008;
El-Kordi et al, 2012; Bodda et al, 2013).
Automated home cage behavior analysis
Automated home cage behavior analysis was performed using
LABORASTM system (Metris b.v., Hoofddorp, the Netherlands),
which consists of a triangular shaped sensor platform (Carbon Fiber
Plate 1000 mm × 700 mm × 30 mm), positioned on 2 orthogonally
placed force transducers (Single Point Load Cells) and a third fixed
point attached to a heavy bottom plate (Corian Plate
980 mm × 695 mm × 48 mm). The whole structure stands on 3
spikes, which are adjustable in height and absorb external vibra-
tions. Mice are housed in clear polycarbonate cages (Makrolon type
II cage, 22 cm × 16 cm × 14 cm) with wood-chip bedding covered
floors. The cage is placed directly onto the sensing platform, with
the upper part of the cage (including top, food hopper and drinking
bottle) suspended in a height-adjustable frame separate from the
sensing platform. Resultant electrical signals caused by mechanical
vibrations as induced by movement of the mouse are transformed
by each force transducer, amplified to a fixed signal range, filtered
to eliminate noise, digitized and stored on a computer. Stored sig-
nals are classified into separate behavioral categories like locomotor
activity, immobility and climbing, and quantified by the LABORASTM
software. Prior to each session, LABORASTM was calibrated. Sponta-
neous mouse behavior was assessed from 6:00 pm until 9:00am,
with 1-h cage habituation prior to initiation of recording. Male
(FVB/N: 10TG, 10WT; C57BL/6N: 12TG, 24WT) and female mice
(FVB/N: 10TG, 10WT; C57BL/6N: 13TG, 28WT) were tested.
Ultrasound vocalizations (USVs)
Ultrasound vocalizations (USVs) were recorded using a microphone
(UltraSoundGateCM16) connected to a preamplifier (UltraSound-
Gate116), which was linked to a computer. At the day of recording,
mice in their home cage (single-housed) were placed in the record-
ing room for 60s. Subsequently, the intruder mouse was put into the
resident’s cage, and vocalization behavior recorded for 3 min. The
intruder mouse was an anesthetized unfamiliar female (anesthetic:
intraperitoneal injection of 0.25% tribromoethanol, 0.1 ml/10 g
body weight). Number of calls per recording session was counted,
and USVs were separated from other sounds using the whistles
detection algorithm of Avisoft-SASLab 5.2 with following selection
criteria: Possible changes per step = 4 (4687 Hz), minimal continu-
ity = 8 ms, possible frequency range = 35–150 kHz. These criteria
had been tested in former studies of mouse USVs (El-Kordi et al,
2012; Hammerschmidt et al, 2012). Avisoft Bioacoustics, Berlin,
Germany, delivered all sound recording hardware and software.
Male C57BL/6N mice (12TG and 23WT) were tested.
The resident–intruder test
The resident–intruder test was used to study inter-male aggression in
various independent cohorts of TG and WT mice of both genetic
backgrounds (FVB/N and C57BL/6N) and different age groups, rang-
ing from 8 to 32 weeks (Jamain et al, 2008; Bodda et al, 2013). As
standard opponents (intruders), group-housed males (4 weeks youn-
ger than resident test males) of C57BL/6N background were
employed (Charles River, Sulzfeld, Germany). An intruder was
introduced into the home cage of the test resident. Observation
started when the resident first sniffed the opponent and stopped
(stop watch) at first attack (defined as bite) to prevent wounding,
but lasted for 300s (FVB/N) or 600s (C57BL/6N) if no attack
occurred (cut-off) (Mineur & Crusio, 2002; Pugh et al, 2004). Male
mice (FVB/N: 12TG, 22WT; C57BL/6N: 10TG, 13WT) were tested.
Over the first 180s (unless mice attacked before), frequency and
duration of following behaviors was additionally quantified in
C57BL/6N (10TG, 11WT): nose/snout and anogenital sniff, following/
chasing.
The social tube test
The social tube test measures social dominance (Messeri et al, 1975;
Moretti et al, 2005; Garfield et al, 2011). The test apparatus com-
prises a 30-cm-long transparent acrylic tube with an internal diame-
ter of 3 cm. Two mice are placed from opposite ends in the tube
and gently pushed to the middle, where they face each other closely.
Single-housed TG and WT C57BL/6N mice were challenged with
unrelated group-housed mice of C57BL/6N background. A subject
was declared “winner” when its opponent completely retreated from
the tube (“out”) within 300s (cut-off). To account for both, win-
ning/losing and time to win/lose, dominance values are calculated
using the following formulas: winner dominance value = 100/time
to out and loser dominance value = 1/(300  time to out). Male
C57BL/6N mice (10TG, 16WT) were tested in this paradigm.
Nest building
Nest building is an important behavior in rodents, reflecting social
competence in reproduction (Deacon, 2006; Satoh et al, 2011; El-
Kordi et al, 2012). Two hours before dark phase, the nesting towel
was removed from home cages of single-housed mice and replaced
by a nestlet (pressed 2.7 g cotton square). Nest building quality was
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scored in the morning (Deacon, 2006; El-Kordi et al, 2012). Male
C57BL/6N mice (10TG, 16WT) were tested.
The pentylenetetrazole-induced seizure protocol
The pentylenetetrazole-induced seizure protocol has been described
in detail previously (Ferraro et al, 1999; Bodda et al, 2013; Wojcik
et al, 2013). Seizure activity was induced in wakeful mice by a sin-
gle intraperitoneal (i.p.) injection of pentylenetetrazole (PTZ)
(50 mg/kg body weight) followed by close observation for 30 min
in a small, clear homecage. Latencies to focal (partial clonic), gener-
alized clonic and maximal tonic-clonic behavioral seizures were
recorded. Furthermore, 4 phases in the continuum of behavioral
response to PTZ injection were defined as follows: (1) Hypoactivity
(progressive decrease in motor activity until resting in a crouched or
prone position with abdomen in full contact with cage bottom); (2)
Partial clonus (clonus seizure activity affecting face, head, and/or
forelimb or forelimbs); (3) Generalized clonus (sudden loss of
upright posture, whole body clonus involving all 4 limbs and tail,
rearing and autonomic signs); and (4) Tonic-clonic (maximal) sei-
zure (generalized seizure characterized by tonic hindlimb extension
—also associated with death). Finally, latencies to partial clonus
(PC), generalized clonus (GC), and tonic-clonic (TC) seizures were
summed to assign each mouse a seizure score that was used as a
quantitative trait measure for mapping according to the following
equation: Seizure score = (0.2)(1/PC latency) + (0.3)(1/GC
latency) + (0.5)(1/TC latency)] × 1000. The weighting factors (0.2,
0.3 and 0.5) in the equation were included as means of incorporat-
ing a measure of the progressive nature of the PTZ-induced seizure
phenotype into the severity rating because generalized clonus is
regarded as a more significant event than partial clonus, and tonic
hind limb extension is regarded as the most severe component of
the phenotype. Therefore, the seizure score reflects the degree of
progression of the seizure phenotype in each mouse.(Ferraro et al,
1999) The test was performed on adult Mecp2 TG of FVB/N and
C57BL/6N background (30–40 weeks old). Male (FVB/N: 6 TG, 10
WT; C57BL/6N: 12 TG, 10 WT) and female mice (FVB/N: 14 TG, 14
WT; C57BL/6N: 10 TG, 11 WT) were tested.
Human sample
Schizophrenic patients (discovery sample)
The GRAS (G€ottingen Research Association for Schizophrenia) data
collection(Ribbe et al, 2010) was approved by the ethics committee
of the Georg-August-University G€ottingen (master committee) and
respective review boards of collaborating centers. The project com-
plies with the Helsinki Declaration. Patients fulfilling DSM-IV crite-
ria for schizophrenia or schizoaffective disorder were included
regardless of disease stage (acute, chronic, residual, or remitted).
All study participants (European Caucasian 95.3%; other 2.0%;
unknown 2.7%) and, if applicable, their legal representatives gave
written informed consent. Of the included 1052 patients, 68.2%
were male (N = 717) and 31.8% female (N = 335). Average age was
39.14  12.56 years (range 17–78).
Healthy controls
Healthy voluntary blood donors were recruited by the Department
of Transfusion Medicine at the Georg-August-University of G€ottingen
according to national guidelines for blood donation. As such, they
widely fulfill health criteria, ensured by a broad predonation
screening process including standardized health questionnaires,
interviews, and assessment of hemoglobin concentration, blood
pressure, pulse, and body temperature. Of the N = 1248 success-
fully genotyped control subjects (European Caucasian 97.8%; other
2%; unknown 0.2%), 61.5% were male (N = 768) and 38.5%
female (N = 480). Average age was 37.44  13.23 years (range
18–69).
Independent schizophrenia sample (replicate sample)
To replicate in an independent sample the phenotype–genotype
associations found in male schizophrenic GRAS patients, data from
male schizophrenic subjects (N = 385) of the Munich/Halle collec-
tion of Dan Rujescu could be analyzed (Van den Oord et al, 2006).
Also in this replicate sample, written informed consent had been
obtained from all subjects after detailed and extensive description of
the study, which was approved by the local ethics committee and
carried out in accordance with the ethical standards laid down in
the Declarations of Helsinki.
Phenotyping—target variables
All schizophrenic patients of the GRAS data collection were compre-
hensively phenotyped (Ribbe et al, 2010). To prove our hypothesis
that MECP2 genotypes modulate aggressive behavior in human sub-
jects, we selected target variables closely related to (poor impulse
control) or predicting (excitement) aggressive behavior in schizo-
phrenic individuals (Arango et al, 1999; Soyka et al, 2007; Colasanti
et al, 2010). To assess the severity of poor impulse control, item 14
of the positive and negative syndrome scale (PANSS) (Kay et al,
1987) was used (“disordered regulation and control of action on
inner urges, resulting in sudden, unmodulated, arbitrary or misdi-
rected discharge of tension and emotions without concern about
consequences”). From the subscale covering positive symptomatol-
ogy, item 4 assessing excitement (“hyperactivity as reflected in
accelerated motor behavior, heightened responsivity to stimuli, hyper-
vigilance or excessive mood lability”) was employed (Tables 2
and 3). Both PANSS readouts were also available in the independent
sample of schizophrenic individuals (replicate sample). The choice
of items is supported by the literature: Cheung and colleagues com-
pared aggressive and non-aggressive schizophrenia patients (aggres-
sion assessed by the Staff Observation Aggression Scale) with
respect to single items of the PANSS (Cheung et al, 1997). The larg-
est group difference was found for the PANSS item “poor impulse
control”. Strikingly, the aggressive group had an average score of 4
(range: 1–7) on this item. Even after controlling for the total level of
psychopathology, the associations of “poor impulse control” and
aggressive behavior remained significant. Additionally, in a more
recent prospective study, “poor impulse control” as measured by
PANSS was highly predictive of aggressive behavior (assessed by
the Overt Aggression Scale)(Nolan et al, 2005).
Phenotyping—control variables
Control variables (and potential confounders) are also presented in
Tables 2 and 3. Sociodemographic data (age, years of education,
unemployment rate), a cognition composite score and clinical vari-
ables describing disease severity were used to characterize the
GRAS sample and exclude potential confounding effects explaining
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the target phenotype–genotype associations. The cognition compos-
ite score(Begemann et al, 2011) represents the mean of 3 z-stan-
dardized neuropsychological measures of higher cognitive
functioning: reasoning ability (Leistungspr€ufsystem subtest 3; Horn,
1983), executive functioning (Trail-Making Test B; Reitan, 1958)
and verbal learning and memory (Verbal Learning and Memory
Test; Helmstaedter et al, 2001). As further clinical variables, the
general, positive and negative scores of the PANSS (target variables
excluded from respective scores), chlorpromazine equivalents (stan-
dardized dosage of antipsychotic medication) (Rijcken et al, 2003;
Woods, 2003) and Global assessment of functioning (GAF; Wittchen
et al, 1997) as measure of impaired psychological, social and occu-
pational performance were used.
DNA extraction, normalization, and genotyping
Genomic DNA was purified from whole blood using JETQUICK
Blood & Cell Culture DNA Spin Kit (Genomed GmbH, L€ohne, Ger-
many) according to the manufacturer’s protocol. Resulting DNA
samples were aliquoted and stored at 80°C. For further analysis,
DNA was normalized to 50 ng/ll with an automated robotic plat-
form (Microlab Star, Hamilton, Bonaduz, Switzerland). For quality
control, each sample was analyzed with a 0.8% agarose gel. Geno-
typing was performed using SimpleProbes (TIB Molbiol, Berlin, Ger-
many) on LightCycler 480 (Roche Diagnostics, Basel, Switzerland),
according to the manufacturer’s instructions.
Transfection studies
Cell lines
Human embryonic kidney 293 (HEK293) and mouse neuroblastoma
(N2a) cells were maintained in DMEM supplemented with 1 g/l glu-
cose, L-glutamine (Glutamax), 5% fetal calf serum, 100U/ml penicil-
linG sodium and 100 lg/ml streptomycin sulfate. For luciferase
assays, cells were seeded into 12-well plates (220,000 cells/well/
2 ml medium), cultured for 24 h and co-transfected using Lipofecta-
mine 2000 (Invitrogen, Karlsruhe, Germany), following the manu-
facturer’s instructions.
Luciferase reporter constructs and detection assay
The reporter plasmids phRL-TK rs2734647C, or rs2734647T, respec-
tively, were constructed by cloning a 30UTR fragment of 346 bp and
including the SNP downstream of the Renilla luciferase open
reading frame, making use of the XbaI restriction site of phRL-TK
(forward primer: 50-ATTATCTAGACCAGGTCTACCCCTCCCGGC-30,
reverse primer: 50-ATTATCTAGAGGCTGCTCCCTGTCCCAGGT-30).
Sequence integrity was verified using Sanger sequencing. Of the
Renilla luciferase reporter construct (phRL-TK rs2734647C, or
rs2734647T, respectively), 1 lg (per well), plus 1 lg (per well) of
the reference construct pCMV-LacZ (Clontech, Mountain View, CA,
USA) were co-transfected in the presence of 10 pg of mirVana miR-
NA mimic hsa-miR-4711-3p, hsa-miR-511, hsa-miR-515-3p, hsa-
miR-519e-3p, negative control #2 (all Life Technologies, Darmstadt,
Germany), or no miRNA, respectively. After 24 h, cells were split in
96-well plates, creating four technical replicates for each condition,
and separately for luciferase and beta-galactosidase measurement.
Enzyme activity was determined using a Mithras LB 940 Plate
Reader (Berthold, Bad Wildbad, Germany). Renilla luciferase activ-
ity was normalized to beta-galactosidase activity.
RNA isolation and quantitative PCR
Peripheral blood mononuclear cells (PBMC) were isolated from cit-
rate blood of men with rs2734647C or rs2734647T genotype (X-chro-
mosomal gene), applying a standard isolation procedure (Ficoll-
Paque Plus, GEHealthcare, M€unchen, Germany). Human RNA was
extracted from deep-frozen human brain samples of adult male sub-
jects who had been free of neuropsychiatric diseases, from placenta
or PBMC, respectively, using a miRNeasy Mini kit (Qiagen, Hilden,
Germany). The same kit was employed for isolation of mouse RNA
from whole E17 embryo (divided into body and head), hippocam-
pus, amygdala, placenta, and cultured microglia. Synthesis of cDNA
was done by the SuperScriptIII system (Invitrogen, Karlsruhe,
Germany). Detection of MECP2 cDNA was performed using SYBR
green (Roche, Diagnostics GmbH, Mannheim, Germany) and specific
primer pairs amplifying the MECP2_e2 isoform (NCBI reference
sequence NM_004992), spanning exons 2–3 (forward primer: 50- CA
GCTCCAACAGGATTCCAT-30, reverse primer: 50- TGGAGGTCCTGG
TCTTCTGA-30), or both isoforms (NM_004992 and NM_001110792),
spanning exons 3–4 (forward primer: 50- AGCTTAAGCAAAGGAAAT
CTGG-30, reverse primer: 50-GCTTTTCCCTGGGGATTG-30). Specific
Taqman microRNA assays were used to detect hsa-miR-511, hsa-
miR-4711-3p, or mmu-miR-511 (Applied Biosystems, Foster City,
CA, USA), following the manufacturer’s instructions. MECP2 expres-
sion levels were normalized to GAPDH, human miRNA expression
levels to RNU43, and mouse miRNA expression levels to sno-142.
Statistics
All experimental data acquisition was done by experimenters una-
ware of group assignment (“‘blinded”). Mouse behavioral data were
analyzed by Mann–Whitney U-test or 2-way analysis of variance
including post hoc Bonferroni testing, where applicable, using
Prism4 (GraphPad Software, San Diego, CA, USA). All data are pre-
sented as mean  s.e.m., unless stated otherwise. Luciferase assay
results from each experiment were normalized to the relative lucif-
erase activity without miRNA co-transfection and analyzed using
one-tailed unpaired t-tests. qPCR results were normalized to the
respective control genes and analyzed using one-tailed unpaired
t-tests. PLINK (v1.07) (Purcell et al, 2007) was used for the analysis
of statistical association between single SNPs and case or control
status (allelic test), and to test for deviations from Hardy–Weinberg
equilibrium. Statistical analyses of phenotype–genotype associations
in the human samples (both GRAS and replicate sample) were per-
formed using SPSS for Windows version 17.0 (SPSS Inc., Chicago,
IL, USA; http://www.spss.com). As MECP2 is X-linked, analyses
were performed separately for men and women. Genotype differ-
ences with respect to the target variables were assessed by analysis
of covariance. Covariates age at examination, years of education,
chlorpromazine equivalents and severity of negative symptoms
(PANSS) were used, as these parameters are likely to influence the
extent to which impulsive aggressive behavior becomes obvious in
a social situation. For the cognition composite score, analysis of
covariance with covariates age, chlorpromazine equivalents and
severity of negative symptoms was applied as these variables have
been widely reported to confound performance on neuropsychologi-
cal tests(Bilder et al, 1992; Hori et al, 2006). Genotype differences
with respect to sociodemographic and clinical measures were tested
19
Martesa Tantra et al MECP2 expression differences in aggression EMBO Molecular Medicine
ª 2014 The Authors EMBO Molecular Medicine
non-parametrically using chi-square (nominal variables) or Mann–
Whitney U/Kruskal–Wallis tests (continuous variables). All P-values
derived from statistical models for the GRAS sample are two-sided
(Tables 2 and 3). For the replicate sample one-sided P-values are
displayed (Table 4). Nominal significance level for all analyses was
set to P < 0.05.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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